What schedule drug is Exalgo?

EXALGO contains hydromorphone, an opioid agonist and a Schedule II controlled substance with an abuse liability similar to other opioid agonists, legal or illicit [see Warnings and Precautions (5.1)].

Do they still make Exalgo?

Exalgo already exists in 8 mg, 12 mg, and 16 mg tableta. Now, there is a 32 mg tablet. Patients who are opioid-tolerant will benefit from this.

Is Exalgo and Dilaudid the same thing?

Hydromorphone is indicated for relief of moderate-to-severe pain. Hydromorphone is marketed under brand names, Dilaudid® and Exalgo®. It is also marketed in generic forms.

Is Exalgo a controlled substance?

EXALGO contains hydromorphone, an opioid agonist and a schedule II controlled substance.

How strong is Exalgo?

EXALGO is available in 8 mg, 12 mg, 16 mg or 32 mg dosage strengths. The 8 mg tablets are round, biconvex, red tablets imprinted with “EXH 8” on one side. The 12 mg tablets are round, biconvex, dark yellow tablets imprinted with “EXH 12” on one side.

Is there a generic for Exalgo?

Camber Pharmaceuticals is pleased to announce that it has launched Hydromorphone ER Tablets, which is the generic version of Exalgo®. Hydromorphone ER Tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Can you cut Exalgo in half?

Instruct patients to swallow EXALGO tablets whole [see PATIENT INFORMATION]. Crushing, chewing, or dissolving EXALGO tablets will result in uncontrolled delivery of hydromorphone and can lead to overdose or death [see WARNINGS AND PRECAUTIONS].

Can Exalgo be crushed?

EXALGO tablets are to be swallowed whole, and are not to be broken, chewed, crushed, dissolved or injected. Taking broken, chewed, crushed, dissolved EXALGO or its contents leads to the rapid release and absorption of a potentially fatal dose of hydromorphone [see Boxed Warning].

Who manufactures Exalgo?

FDA Approves Mallinckrodt’s EXALGO® (hydromorphone HCl) Extended-Release Tablets 32 mg (CII) for Opioid-Tolerant Patients with Moderate-to-Severe Chronic Pain | Fierce Biotech.